Subscribe to STAT’s news feed.
Click on “Follow” and decide if you want to get news from STAT via RSS, as email newsletter, via mobile or on your personal news page.
Subscription to STAT comes without risk as you can unsubscribe instantly at any time.
You can also filter the feed to your needs via topics and keywords so that you only receive the news from STAT which you are really interested in. Click on the blue “Filter” button below to get started.
Website title: STAT | Reporting from the frontiers of health and medicine
Is this your feed? Claim it!
On this week’s episode of “The Readout LOUD”: the failure of two closely followed heart disease drugs and how these setbacks may impact the future of cardiovascular drug research. Plus, drug safety concerns weigh on some of the biggest companies in the sector.
For years, it was widely believed that a deeper understanding of genetics was going to speed th...
MILWAUKEE — Kat Zilka sat on the floor of her living room, beside a glowing Christmas tree and a pile of essays, and felt like weeping. It was late in 2022, and she had asked her 12th grade digital journalism students to reflect on their relationships to devices.
“The things they were writing were deeply disturbing,” she said.
Teenagers quietly enduring ...
This is the second of two pieces about the experiencing of pre-clinical Alzheimer’s. Read the first here.
In 1976, at the dawn of the modern Alzheimer’s era, the neurologist Robert Ka...
The investigation started with a tip from a British couple.
After trying to have a second child for several years, they had signed up with a U.S.-based company called International Fertility Group (IFG), paying tens of thousands of dollars for access abroad to an
Pharma companies that make GLP-1 drugs have increasingly promoted telehealth companies that prescribe the popular treatments. With a new deal announced this week, one of those relationships is expected to grow more complicated.
Eli Lilly has been featuring a telehealth company called Counsel Health on